ArticleFrontiers in molecular biosciences2023

Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer.

Shreya Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.